Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H13ClN4.2ClH |
Molecular Weight | 297.612 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.ClC1=NN=C(C=C1)N2C[C@@H]3CC[C@H](C2)N3
InChI
InChIKey=FMBGHZXNKMHVDT-QFHMQQKOSA-N
InChI=1S/C10H13ClN4.2ClH/c11-9-3-4-10(14-13-9)15-5-7-1-2-8(6-15)12-7;;/h3-4,7-8,12H,1-2,5-6H2;2*1H/t7-,8+;;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C10H13ClN4 |
Molecular Weight | 224.69 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11772288Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9513595 | http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-2299(199703)40:3%3C251::AID-DDR5%3E3.0.CO;2-J/abstract | http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-2299(199810)45:2%3C45::AID-DDR1%3E3.0.CO;2-Q/full
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11772288
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9513595 | http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-2299(199703)40:3%3C251::AID-DDR5%3E3.0.CO;2-J/abstract | http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-2299(199810)45:2%3C45::AID-DDR1%3E3.0.CO;2-Q/full
DBO-83 is a 3,8-diazabicyclo[3.2.1]octane derivative with
antinociceptive properties. DBO-83 exhibits high affinity for the α4β2 subtype and is a full agonist at α4β2 and ganglionic receptors but lacks appreciable activity at neuromuscular receptors. DBO-83 exhibits antinociceptive activity in both rat and mouse models of acute and persistent
pain. In addition DBO-83 modulates memory functions in rodents.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9513595
Curator's Comment: 1998
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1907589 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9513595 |
4.1 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:00:29 GMT 2023
by
admin
on
Sat Dec 16 08:00:29 GMT 2023
|
Record UNII |
M16W0AK91T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70585137
Created by
admin on Sat Dec 16 08:00:29 GMT 2023 , Edited by admin on Sat Dec 16 08:00:29 GMT 2023
|
PRIMARY | |||
|
M16W0AK91T
Created by
admin on Sat Dec 16 08:00:29 GMT 2023 , Edited by admin on Sat Dec 16 08:00:29 GMT 2023
|
PRIMARY | |||
|
195211-53-1
Created by
admin on Sat Dec 16 08:00:29 GMT 2023 , Edited by admin on Sat Dec 16 08:00:29 GMT 2023
|
PRIMARY | |||
|
16219278
Created by
admin on Sat Dec 16 08:00:29 GMT 2023 , Edited by admin on Sat Dec 16 08:00:29 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |